HomeProductsKey IntermediatesDapagliflozin Powder CAS 461432-26-8 for Diabetes Treatment

Dapagliflozin Powder CAS 461432-26-8 for Diabetes Treatment

$2 - 3 /Gram
100 /Gram (Min. Order)
Payment Type:
T/T,Paypal
Incoterm:
FOB
Min. Order:
100 Gram
Transportation:
Land,Air,Express,Ocean
Port:
Shanghai,Shenzhen,Guangzhou
Share:
Chat Now
  • Product Description
Overview
Product Attributes

Model No.Dapagliflozin

BrandRhine

GradePhamaceutical Grade

Place Of OriginChina

Test MethodHPLC UV COA

Specification10g:vial/bag

PackageBottles, foil bags

TrademarkRHINE

Sec-HPLC99.5%

Cas760937-92-6

Molecular FormulaC21H25ClO6

MW408.875

Supply Ability & Additional Information

PackagingFoil bag /bottle

Productivity10 kg per month

TransportationLand,Air,Express,Ocean

Place of Originchina

Supply Ability500 grams/month

CertificateN/A

HS Code2934993000

PortShanghai,Shenzhen,Guangzhou

Payment TypeT/T,Paypal

IncotermFOB

Packaging & Delivery
Selling Units:
Gram
Package Type:
Foil bag /bottle
Dapagliflozin is a new type of antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca. It was approved by the European Medicines Agency (EMA) on November 12, 2012 and is the first to be approved. SGLT2 inhibitors for the treatment of type 2 diabetes are important candidates for the treatment of diabetes. They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Key Intermediates  Sarms  Bodybuilding Peptide ...

Product Categories : Key Intermediates

Email to this supplier
  • *Subject:
  • *To:
    Ms. Caroline
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
Send Inquiry
*
*

HomeProductsKey IntermediatesDapagliflozin Powder CAS 461432-26-8 for Diabetes Treatment
Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send